Concepedia

Akash R. Boda

AR

6

Publications

322

Citations

6

H-Index

2014

Active since

Affiliations

Philip Morris International (Switzerland)(Current)

The University of Texas MD Anderson Cancer Center

Akash R. Boda is an author at Philip Morris International (Switzerland) specializing in medicine, cell biology, and t cell immunity.

ORCID

Top concepts

Publications per year

2014–2022

6

Publications

6

ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

Cheng‐En Hsieh, Sunil Krishnan, Ren‐Chin Wu et al. · Science Immunology · 2022 · 140 citations · Full text

, , +17

High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege

Casey R. Ager, Akash R. Boda, Kimal Rajapakshe et al. · Journal for ImmunoTherapy of Cancer · 2021 · 65 citations · Full text

Identification of a novel <scp>PPAR</scp> β/δ/miR‐21‐3p axis in <scp>UV</scp> ‐induced skin inflammation

Gwendoline Degueurce, Ilenia D’Errico, Christine Pich-Bavastro et al. · EMBO Molecular Medicine · 2016 · 46 citations · Full text

RaftProt: mammalian lipid raft proteome database

Anup D. Shah, David Chen, Akash R. Boda et al. · Nucleic Acids Research · 2014 · 39 citations · Full text

, , +17

Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructure

Stéphanie Boué, Thomas E. Exner, Samik Ghosh et al. · F1000Research · 2017 · 16 citations · Full text

, , +28

Rows per page

1–5 of 6